Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Gains from Investment Securities (2019 - 2025)

Historic Gains from Investment Securities for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to $332000.0.

  • Biodesix's Gains from Investment Securities fell 9173.92% to $332000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $332000.0, marking a year-over-year decrease of 9173.92%. This contributed to the annual value of $4.2 million for FY2024, which is 10396.86% up from last year.
  • Biodesix's Gains from Investment Securities amounted to $332000.0 in Q3 2025, which was down 9173.92% from $6.9 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Gains from Investment Securities registered a high of $6.9 million during Q2 2025, and its lowest value of -$58000.0 during Q4 2023.
  • Moreover, its 5-year median value for Gains from Investment Securities was $2.8 million (2022), whereas its average is $2.3 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first crashed by 12396.69% in 2023, then skyrocketed by 93620.69% in 2024.
  • Over the past 5 years, Biodesix's Gains from Investment Securities (Quarter) stood at $2.9 million in 2021, then crashed by 91.56% to $242000.0 in 2022, then tumbled by 123.97% to -$58000.0 in 2023, then soared by 936.21% to $485000.0 in 2024, then crashed by 31.55% to $332000.0 in 2025.
  • Its last three reported values are $332000.0 in Q3 2025, $6.9 million for Q2 2025, and $378000.0 during Q1 2025.